6610 POSTER Safety of bevacizumab treatment in non-small cell lung cancer (NSCLC) subjects receiving full-dose anti-coagulation (FDAC) treated on protocol BO17704
暂无分享,去创建一个
H. Kuo | G. Chang | N. Leighl | M. Reck | M. Gottfried | J. Bennouna | J. Trigo | A. Kunitsyn | J. Cosaert | B. Szima